From: Early predictors and screening tool developing for severe patients with COVID-19
Characteristics |
Fatal cases (n = 37) |
Severe cases (n = 123) | Common cases (n = 653) | χ2 | P |
---|---|---|---|---|---|
Age |
61.0 (55.0, 74.5) |
57.0 (47.0, 68.0) |
47.0 (35.0, 56.0) | 78.7 | < 0.001 |
Age groups | 74.8 | < 0.001 | |||
< 45 | 2.7% | 20.3% | 44.0% | ||
45–59 | 37.8% | 34.1% | 36.8% | ||
≥ 60 | 59.5% | 45.6% | 19.2% | ||
Male | 54.1% | 63.4% | 49.0% | 8.7 | 0.013 |
Exposure in the past 14 days | |||||
Have been to Wuhan or other places with patient | 60.0% | 55.0% | 51.2% | 1.3 | 0.524 |
Exposure to diagnosed patient | 30.6% | 21.7% | 30.4% | 3.6 | 0.166 |
Exposure to symptomatic patient | 33.3% | 24.8% | 33.9% | 3.5 | 0.177 |
Days from illness onset to visit hospital |
3.0 (1.0, 4.0) |
3.0 (1.0, 5.0) |
3.0 (1.0, 5.8) | 0.1 | 0.953 |
Days from visit hospital to be defined |
6.9 (5.2, 9.4) |
7.5 (5.0, 9.9) |
7.9 (5.4, 10.9) | 0.9 | 0.653 |
Cluster case | 24.1% | 19.6% | 28.5% | 3.5 | 0.177 |
Comorbidity | 103.4 | < 0.001 | |||
None | 5.4% | 59.1% | 77.8% | ||
One disease | 64.9% | 26.1% | 15.0% | ||
Two diseases | 21.6% | 13.0% | 6.0% | ||
Three diseases and more | 8.1% | 1.8% | 1.2% |